EAGAN, Minn., Dec. 20, 2024 /PRNewswire/ — Tareen Development Partners is pleased to announce the acquisition of a medical office building, Town Centre Plaza, located at 1185 Town Centre Drive, Eagan, MN 55123. The property will be rebranded as Eagan Medical Center, marking a strategic step in enhancing healthcare services in the region and establishing the center as a premier destination for medical care in Minnesota.
Basir Tareen, owner of Tareen Development Partners, shared his vision for the acquisition: “We plan to rebrand the building as Eagan Medical Center and are working closely with a leading medical group to fully occupy the building. With Minnesota’s largest independently-owned gastrointestinal and dermatology groups already on board, we aim to attract another large medical group to further expand services for patients and the community.” The new ownership group is also dedicated to enhancing the building and upgrading amenities for tenants.
In addition to Tareen Dermatology, the building hosts several distinguished tenants, including MNGI, Integrative Therapy Group, and Sparz Vein Clinic. This collaboration will foster a comprehensive healthcare ecosystem under the Eagan Medical Center brand, offering a wide range of medical specialties and services.
Dr. Mohiba Tareen of Tareen Dermatology expressed her enthusiasm for the project: “This office holds a special place for me as it was the home of my late dear friend Dr. Crutchfield and his wonderful practice — Crutchfield Dermatology. We are honored to continue growing and addressing the healthcare needs of Eagan and the surrounding community.
For more information about Eagan Medical Center and Tareen Development Partners, please contact:
Natalie Borer
Natalie@tdpmn.com
612.559.4791
SOURCE Tareen Development Partners
Data to be presented in Clinical Trials in Progress Session on Monday, April 28, 2025CORAL…
More than 50% of men now face erectile dysfunction after the age of 40. In…
BEIJING, April 27, 2025 (GLOBE NEWSWIRE) -- On April 25, 2025, the 66th (Spring 2025)…
After six months of research on the ingredients and thousands of feedback from real consumers,…
Data Presented at the AUA Meeting Reflect Longest-Term Data among FIT InterventionsSOUTH SAN FRANCISCO, Calif.,…
- Robust 24-month complete response rate of 42.3% by K-M for cretostimogene monotherapy in BOND-003…